Whitehawk Therapeutics, Inc.
WHWK
$4.16
$0.051.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 7.15M | 14.38M | 21.60M | 27.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 7.15M | 14.38M | 21.60M | 27.78M |
| Cost of Revenue | 99.41M | 91.72M | 87.84M | 84.30M | 49.36M |
| Gross Profit | -99.41M | -84.58M | -73.46M | -62.70M | -21.58M |
| SG&A Expenses | 23.30M | 29.82M | 35.01M | 36.99M | 38.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 122.70M | 121.55M | 122.85M | 121.29M | 88.30M |
| Operating Income | -122.70M | -114.40M | -108.46M | -99.69M | -60.53M |
| Income Before Tax | -115.81M | -20.60M | -15.62M | -10.42M | 27.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -115.81 | -20.60 | -15.62 | -10.42 | 27.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.81M | -20.60M | -15.62M | -10.42M | 27.61M |
| EBIT | -122.70M | -114.40M | -108.46M | -99.69M | -60.53M |
| EBITDA | -122.68M | -114.32M | -108.34M | -99.52M | -60.33M |
| EPS Basic | -1.67 | 0.49 | 0.15 | -0.06 | 0.16 |
| Normalized Basic EPS | -1.05 | -1.07 | -1.28 | -1.35 | -1.22 |
| EPS Diluted | -1.68 | 0.47 | 0.13 | -0.07 | 0.15 |
| Normalized Diluted EPS | -1.05 | -1.07 | -1.28 | -1.35 | -1.21 |
| Average Basic Shares Outstanding | 276.74M | 247.14M | 205.02M | 162.85M | 120.78M |
| Average Diluted Shares Outstanding | 276.74M | 247.43M | 205.31M | 163.14M | 121.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |